Assenagon Asset Management
AGIO icon

Assenagon Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Assenagon Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.86M Buy
103,955
+36,802
+55% +$1.12M ﹤0.01% 708
2026
Q1 		$2.27M Sell
67,153
-43,287
-39% -$1.23M ﹤0.01% 759
2025
Q4 		$3.01M Buy
110,440
+43,287
+64% +$1.52M ﹤0.01% 766
2025
Q3 		$2.7M Buy
+67,153
New +$2.53M ﹤0.01% 770
2024
Q4 		– Sell
-7,409
Closed -$329K – 1314
2024
Q3 		$329K Sell
7,409
-127,571
-95% -$5.79M ﹤0.01% 1288
2024
Q2 		$5.82M Sell
134,980
-319,821
-70% -$11.5M 0.01% 587
2024
Q1 		$13.3M Buy
454,801
+404,297
+801% +$10.8M 0.03% 364
2023
Q4 		$1.12M Buy
50,504
+41,768
+478% +$936K ﹤0.01% 1070
2023
Q3 		$216K Hold
8,736
– – ﹤0.01% 1333
2023
Q2 		$247K Sell
8,736
-89,847
-91% -$2.24M ﹤0.01% 1257
2023
Q1 		$2.26M Sell
98,583
-13,905
-12% -$369K 0.01% 792
2022
Q4 		$3.16M Buy
112,488
+18,839
+20% +$531K 0.01% 660
2022
Q3 		$2.65M Sell
93,649
-15,653
-14% -$420K 0.01% 632
2022
Q2 		$2.42M Buy
+109,302
New +$2.47M 0.01% 760
2020
Q3 		– Sell
-51,412
Closed -$2.75M – 1104
2020
Q2 		$2.75M Buy
+51,412
New +$2.38M 0.02% 497

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Assenagon Asset Management's AGIO Position: Q2 2026 in Review

Assenagon Asset Management increased its Agios Pharmaceuticals (AGIO) stake by 55% in Q2 2026, buying an estimated $1.12M and bringing the position to 103,955 shares worth $3.86M. The position accounts for ﹤0.01% of the portfolio, ranked #708.

Assenagon Asset Management first reported a position in AGIO in Q2 2020 and has held it in 15 quarters since. The position peaked at $13.3M in Q1 2024. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Assenagon Asset Management held 103,955 shares of Agios Pharmaceuticals worth $3.86M as of Q2 2026.
  • Assenagon Asset Management bought 36,802 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
  • Agios Pharmaceuticals made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #708 holding.
  • Assenagon Asset Management first reported a position in Agios Pharmaceuticals in Q2 2020 and has held it in 15 quarters since.
  • Assenagon Asset Management's Agios Pharmaceuticals position peaked at $13.3M in Q1 2024.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.